Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumors

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors

NCT00420485

Conditions: Solid Tumors
Locations: Novartis Investigative Site Vancouver, British Columbia, Canada

MD Anderson Cancer Center - Orlando Toronto, Ontario, Canada

Novartis Investigative Site Copenhagen, Denmark

Novartis Investigative Site Dijon, France

View Trial Details

Completed

A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

NCT00586092

Conditions: Solid Tumors
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Gemcitabine and Dasatinib in Advanced Solid Tumors

NCT00429234

Conditions: Advanced Cancer, Solid Tumors
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Effects of OM-174 in Adult Patients With Solid Tumors

NCT01800812

Conditions: Solid Tumors
Locations: Not specified

View Trial Details

Completed

Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer

NCT00529022

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

NCT00791063

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +7 more
Locations: Not specified

View Trial Details

Completed

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

NCT00500422

Conditions: Solid Tumors
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bevacizumab and Bortezomib in Patients With Advanced Malignancy

NCT00428545

Conditions: Advanced Malignancy, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

NCT00611689

Conditions: Neoplasms, Refractory Malignancy, Solid Tumors
Locations: Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

A Study of LY2523355 in Patients With Solid Cancer

NCT01358019

Conditions: Solid Tumors
Locations: Tokyo, Japan

View Trial Details